Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · Real-Time Price · USD

0.9931

-0.0053 (-0.53%)

Dec 12, 2025, 4:00 PM EST - Market closed

Oncolytics Biotech Employees

Oncolytics Biotech had 28 employees as of December 31, 2024. The number of employees decreased by 1 or -3.45% compared to the previous year.

Employees

28

Change

-1

Growth

-3.45%

Revenue / Employee

n/a

Profits / Employee

-$904,312

Market Cap

105.41M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	28	-1	-3.45%
Dec 31, 2022	29	3	11.54%
Dec 31, 2021	26	1	4.00%
Dec 31, 2020	25	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

ONCY News

4 days ago - Oncolytics Biotech® Reschedules Special Meeting of Shareholders to Change Jurisdiction of Incorporation to Nevada - Business Wire
23 days ago - Oncolytics Biotech® Provides Update on Special Meeting of Shareholders - Business Wire
24 days ago - Oncolytics Biotech® Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer - Business Wire
6 weeks ago - Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care - PRNewsWire
7 weeks ago - Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada - PRNewsWire
2 months ago - Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study - PRNewsWire
3 months ago - Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion - PRNewsWire
3 months ago - Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions - PRNewsWire